By
Drug Target Review2025-10-29T10:28:41
Scientists have identified an overactive brain cell type linked to schizophrenia-like symptoms in mice – a discovery that could lead to new, targeted treatments to prevent cognitive impairments.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-20T08:00:00Z
Contributor Dr Rahul Gupta, By Drug Target Review
2026-11-18T11:12:00Z
2026-11-18T07:00:00Z
Contributor Dr Bryan McClellan and Dr William Matsui, By Drug Target Review
2026-07-08T07:58:00
Contributor Dr Nick Lynch, By Dr Raminderpal Singh
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2023-02-13T11:57:11
Sponsored by Agilent
2026-10-07T14:00:00
Sponsored by WuXi AppTec
2023-04-17T14:45:00
Sponsored by Sartorius, By Drug Target Review
2026-06-29T06:49:00
Contributor Laura Alvarez, By Drug Target Review
Site powered by Webvision Cloud